MarketInOut Stock Screener Log In | Sign Up

Biocon Ltd

BSE • Healthcare • Biotechnology • Quote as of 10/28/2026 09:08
Biocon Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization534,890 mln
Float737 mln
Earnings Date11/04/2026

EPS

3.38
Stretched

P / E

98.76
Speculative

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.37
Borderline

1-Year Forecast

440.68
Strong upside

Relative Strength

55 / 100
Slightly ahead

Business Description

Founded in 1978 and based in Bengaluru, India, Biocon Limited is a biotechnology company that develops and sells a broad range of medicines, including treatments for diabetes, cancer, heart disease, and autoimmune conditions. The company operates across India, the United States, Ireland, and other global markets through its generics, biosimilars, and research divisions. Biocon also partners with pharmaceutical and healthcare companies worldwide to support drug discovery, clinical research, and manufacturing.

Key Fundamentals

EPS3.38
P/E98.76
ROE1.66
RPS118
ROIC2.43
ROA0.78
Interest Cover1.60
EBITDA, mln34,545
EV / EBITDA22.07
EV / EBIT54.26
Revenue, mln173,211
EV / Revenue4.40

Quote Details

Last 332.10
Change -1.7 (-0.51%)
Open 332.10
Volume 159
Turnover 52,804
Average Volume 131,075

Financial Ratios

Pre-Tax Profit Margin3
Leverage Ratio1.84
Current Ratio1.23
Price / Book1.61
Price / Tangible Book6.98
Price / Cash Flow65.31
Debt / Equity0.44
Price / Sales3.14
PEG Ratio4.93

Financial Strength

Altman Z-Score1.76
Piotroski F-Score 6 / 9
Beneish M-Score-2.37
Price to Intrinsic Value1.86
Price to Lynch Fair Value4.80
Price to Graham Number4.82
1-Year Target Price440.68
Shiller PE Ratio53.17

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.42% 61 / 100   
1 Month -12.83% 23 / 100   
2 Months -24.68% 14 / 100   
6 Months -8.15% 54 / 100   
1 Year -6.34% 64 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog